Treatment Decisions in Metastatic Melanoma: Immunotherapy vs Targeted Therapy
Source: Cancer Network, December 2024
Panelists discuss how treatment decisions in metastatic melanoma involve balancing the benefits of immunotherapy versus targeted therapy, taking into account factors such as tumor genetics, patient response, and tolerability.
